Published in Hum Brain Mapp on July 01, 2007
The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques. Neuroimage (2009) 1.81
Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology (2010) 1.62
Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients. Proc Natl Acad Sci U S A (2010) 1.12
Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacology (2011) 1.10
Self-referenced processing, neurodevelopment and joint attention in autism. Autism (2010) 1.08
Differential regional gray matter volumes in patients with on-line game addiction and professional gamers. J Psychiatr Res (2012) 0.98
Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 0.98
Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. Neuroimage (2012) 0.96
Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate. Eur J Neurosci (2010) 0.86
The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults. Exp Clin Psychopharmacol (2013) 0.82
Methylphenidate modulates activity within cognitive neural networks of patients with post-stroke major depression: A placebo-controlled fMRI study. Neuropsychiatr Dis Treat (2008) 0.78
Posterior versus frontal theta activity indexes approach motivation during affective autobiographical memories. Cogn Affect Behav Neurosci (2015) 0.77
Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine. Neuropharmacology (2016) 0.76
Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398. J Neural Transm (Vienna) (2008) 0.75
The effects of methylphenidate on cerebral responses to conflict anticipation and unsigned prediction error in a stop-signal task. J Psychopharmacol (2016) 0.75
The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder. Neuroimage Clin (2016) 0.75
Laboratory-induced learned helplessness attenuates approach motivation as indexed by posterior versus frontal theta activity. Cogn Affect Behav Neurosci (2017) 0.75
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study. Lancet Neurol (2012) 2.22
Reduced spontaneous but relatively normal deliberate vicarious representations in psychopathy. Brain (2013) 1.86
A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up. J Clin Psychiatry (2010) 1.54
Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. J Am Acad Child Adolesc Psychiatry (2004) 1.53
AL amyloidosis treated with induction chemotherapy with VAD followed by high dose melphalan and autologous stem cell transplantation. Amyloid (2002) 1.44
Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome? J Surg Oncol (2006) 1.40
Tumor necrosis factor receptor cross-talk. FEBS J (2011) 1.40
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol (2014) 1.36
Changes in cortical grey matter density associated with long-standing retinal visual field defects. Brain (2009) 1.27
Brain activation during human male ejaculation. J Neurosci (2003) 1.27
Gender differences in the relation between social support, problems in parent-offspring communication, and depression and anxiety. Soc Sci Med (2004) 1.23
Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats. Sleep (2008) 1.19
Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans. J Cereb Blood Flow Metab (2009) 1.19
rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Biol Psychiatry (2002) 1.15
Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response. Psychiatr Genet (2007) 1.10
Symptom dimensions in OCD: item-level factor analysis and heritability estimates. Behav Genet (2010) 1.10
Impaired attribution of emotion to facial expressions in anxiety and major depression. PLoS One (2010) 1.06
Maternal separation decreases adult hippocampal cell proliferation and impairs cognitive performance but has little effect on stress sensitivity and anxiety in adult Wistar rats. Behav Brain Res (2010) 1.05
Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J (2012) 1.03
The diagnostic value of 124I-PET in patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging (2008) 1.02
Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosom Med (2008) 1.01
Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism. J Nucl Med (2003) 1.00
Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates. Neuroimage (2010) 0.99
Phenylketonuria: High plasma phenylalanine decreases cerebral protein synthesis. Mol Genet Metab (2009) 0.99
Detection and grading of soft tissue sarcomas of the extremities with (18)F-3'-fluoro-3'-deoxy-L-thymidine. Clin Cancer Res (2004) 0.99
Striatal dopa and glucose metabolism in PD patients with freezing of gait. Mov Disord (2006) 0.99
3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma? J Nucl Med (2003) 0.98
Serotonin transporter intron 2 polymorphism associated with rigid-compulsive behaviors in Dutch individuals with pervasive developmental disorder. Am J Med Genet B Neuropsychiatr Genet (2005) 0.96
Activations of "motor" and other non-language structures during sentence comprehension. Brain Lang (2004) 0.96
Dissociable effects of methylphenidate, atomoxetine and placebo on regional cerebral blood flow in healthy volunteers at rest: a multi-class pattern recognition approach. Neuroimage (2012) 0.96
Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism. Psychosom Med (2005) 0.94
Fact or factitious? A psychobiological study of authentic and simulated dissociative identity states. PLoS One (2012) 0.94
Locally increased P-glycoprotein function in major depression: a PET study with [11C]verapamil as a probe for P-glycoprotein function in the blood-brain barrier. Int J Neuropsychopharmacol (2009) 0.93
Psychobiological characteristics of dissociative identity disorder: a symptom provocation study. Biol Psychiatry (2006) 0.92
Absolute quantitative total-body small-animal SPECT with focusing pinholes. Eur J Nucl Med Mol Imaging (2010) 0.92
Men versus women on sexual brain function: prominent differences during tactile genital stimulation, but not during orgasm. Hum Brain Mapp (2009) 0.92
A forced desynchrony study of circadian pacemaker characteristics in seasonal affective disorder. J Biol Rhythms (2002) 0.92
The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J Alzheimers Dis (2012) 0.92
Gender-specific effects of social housing in rats after chronic mild stress exposure. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.92
Future antidepressants: what is in the pipeline and what is missing? CNS Drugs (2004) 0.91
Effect of fenfluramine-induced increases in serotonin release on [18F]MPPF binding: a continuous infusion PET study in conscious monkeys. Synapse (2006) 0.90
Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation. Psychosom Med (2004) 0.90
Mood regulation in seasonal affective disorder patients and healthy controls studied in forced desynchrony. Psychiatry Res (2003) 0.90
Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient mice. Behav Brain Res (2013) 0.88
Event-related fMRI responses in the human frontal eye fields in a randomized pro- and antisaccade task. Exp Brain Res (2002) 0.88
Antiaggressive activity of central oxytocin in male rats. Psychopharmacology (Berl) (2013) 0.87
An animal model of emotional blunting in schizophrenia. PLoS One (2007) 0.87
TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates. Neurobiol Dis (2003) 0.86
Phenylketonuria: reduced tyrosine brain influx relates to reduced cerebral protein synthesis. Orphanet J Rare Dis (2013) 0.86
Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood-brain barrier: an experimental PET study in rats. J Psychopharmacol (2009) 0.84
Bilateral sensory abnormalities in patients with unilateral neuropathic pain; a quantitative sensory testing (QST) study. PLoS One (2012) 0.84
Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parameters. Psychopharmacology (Berl) (2005) 0.83
Cost-effectiveness of escitalopram in major depressive disorder in the Dutch health care setting. Clin Ther (2012) 0.83
Perception of burden experienced during diagnostic tests by melanoma patients with lymph node metastases. Melanoma Res (2009) 0.83
Fighting stigma of mental illness in midsize European countries. Soc Psychiatry Psychiatr Epidemiol (2012) 0.82
Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin. Neuropsychopharmacology (2005) 0.82
Dysfunctional beliefs in the process of change of cognitive treatment in obsessive compulsive checkers. Clin Psychol Psychother (2010) 0.82
Influence of iterative image reconstruction on CT-based calcium score measurements. Int J Cardiovasc Imaging (2014) 0.82
The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 0.81
Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function. Psychiatry Res (2010) 0.81
Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors. J Neurochem (2009) 0.81
Considerations for generic oncology FDG-PET/CT protocol preparation in drug development. IDrugs (2007) 0.81
Ketamine administration disturbs behavioural and distributed neural correlates of fear conditioning in the rat. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.80
Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications. Eur J Nucl Med Mol Imaging (2010) 0.80
Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases. Ann Surg Oncol (2006) 0.80
Investigating the molecular basis of major depressive disorder etiology: a functional convergent genetic approach. Ann N Y Acad Sci (2008) 0.80
The effect of chronic selective serotonin reuptake inhibitor treatment on serotonin 1B receptor sensitivity and HPA axis activity. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.79
Brain activation during human male ejaculation revisited. Neuroreport (2007) 0.79
Biochemical and behavioral effects of long-term citalopram administration and discontinuation in rats: role of serotonin synthesis. Neurochem Int (2010) 0.79
The use of radiotracers in drug discovery and development. Drug Discov Today (2003) 0.78
The yale-brown obsessive-compulsive scale: factor structure of a large sample. Front Psychiatry (2010) 0.78
In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta. J Cereb Blood Flow Metab (2004) 0.78
Source of impaired image quality in 3D whole-body FDG PET scanning. Eur J Nucl Med Mol Imaging (2004) 0.78
Processes of change in cognitive-behavioural treatment of obsessive-compulsive disorder: Current status and some future directions. Clin Psychol Psychother (2010) 0.77
Somatosensory profiles but not numbers of somatosensory abnormalities of neuropathic pain patients correspond with neuropathic pain grading. PLoS One (2012) 0.77
Analysis of 5-HT(2A) receptor binding with [(11)C]MDL 100907 in rats: optimization of kinetic modeling. Mol Imaging Biol (2013) 0.77
Latent class analysis of the Yale-Brown Obsessive-Compulsive Scale symptoms in obsessive-compulsive disorder. Compr Psychiatry (2010) 0.77
Comparison of brain and blood gene expression in an animal model of negative symptoms in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.76
Despite irreversible binding, PET tracer [11C]-SA5845 is suitable for imaging of drug competition at sigma receptors-the cases of ketamine and haloperidol. Neurochem Int (2008) 0.76
Cerebral metabolic effects of intravenous glycine in healthy human subjects. J Clin Psychopharmacol (2006) 0.76
Lithium concentrations in plasma of lithium-treated psychiatric patients in the Netherlands: commentary on Cusin et al. Psychiatry Res (2002) 0.75
Despite higher glucocorticoid levels and stress responses in female rats, both sexes exhibit similar stress-induced changes in hippocampal neurogenesis. Behav Brain Res (2012) 0.75
Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat. NMR Biomed (2004) 0.75
Implications of mediastinal uptake of 131I with regard to surgery in patients with differentiated thyroid carcinoma. Cancer (2005) 0.75
Circulating cerebral S100B protein is associated with depressive symptoms following myocardial infarction. Neuropsychobiology (2009) 0.75
Radioactive seed localization is the preferred technique in nonpalpable breast cancer compared with wire-guided localization and radioguided occult lesion localization. Nucl Med Commun (2017) 0.75
Acute social defeat does not alter cerebral 5-HT2A receptor binding in male Wistar rats. Synapse (2014) 0.75
A sarcoid-like reaction in a patient with hemangiopericytoma--mediastinal lymphadenopathy resulting in confusion about therapy. Acta Oncol (2003) 0.75
The Psychobiology of Authentic and Simulated Dissociative Personality States: The Full Monty. J Nerv Ment Dis (2016) 0.75
Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined. J Affect Disord (2013) 0.75
Screening of the epsilon sarcoglycan gene in Tourette syndrome and obsessive compulsive disorder. Psychiatr Genet (2008) 0.75
Left ventricular volume assessment by planar radionuclide ventriculography evaluated by MRI. Nucl Med Commun (2009) 0.75